newsfilter
← Latest News
Bloomberg·

Biotechs Get Wall Street Nod on New Blood Disorder Drugs Data

Biotechnology stocks initially moved higher as Wall Street cheered updates for a range of therapies to treat blood disorders like sickle cell disease and beta thalassemia.